chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from medical assistant referring to unspecified patients of unknown age and gender. The information about patients' concurrent conditions, medical history, concomitant medications was unknown. On 22-OCT-2021, doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and varicella virus vaccine live (oka/merck) (VARIVAX) were exposed to 54.9 Fahrenheit for 2 hours 1 minute. It was reported that there was no previous temperature excursion. On an unknown date in 2021, three improperly stored doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot number T012807 has been verified to be a valid lot number, expiration date was 14-APR-2022) and two improperly stored doses of varicella virus vaccine live (oka/merck) (VARIVAX) (lot number U015847 has been verified to be a valid lot number, expiration date was 19-MAY-2023) were administered to unspecified amount of patients for prophylaxis (strengths, doses, vaccinate schemes, route of administration, and anatomical location were not reported) (product storage error). No further information, adverse event or product quality complaints were reported. This is a non- valid report due to lac of patients.
Redness and swelling, itching with a few blisters on 3/4 of upper left arm - onset approximately 24 hrs after Flu vaccine and spreading down arm towards elbow - some relief at 24 hrs after BENADRYL 125mg PO Q 4 hrs and hydrocortisone cream.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Aug-2021 at 9:47 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 19-Aug-2021 at 9:47 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 19-Aug-2021 at 9:47 AM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Got sick at the end of November, went to the doctor that Saturday tested positive for influenza and Covid.
Hives; severe arm aches; itching; headache; This is a spontaneous report from a contactable other healthcare professional (patient). A 45-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EL3246) via intramuscular in left arm on 05Feb2021 at 11:30 am as a single dose for COVID-19 immunization. Medical history included celiac disease and PCN allergies. The patient's concomitant medication included Cannabis. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since vaccination, the patient was not tested for COVID-19. On 05Feb2021 at 12:45 pm, patient experienced hives, severe arm aches, itching and headache. Treatment provided for the events was unknown. Outcome of the events was recovering.
Severe continual migraine (almost 24 hours each  day for several months), with accompanying severe neck spasm and pain.
From initial information received on 27Jun05 from a health care professional regarding an adverse event occurring, it was reported that a male pt, age not specified, received a dose of Menactra vaccine, lot number U1589AA, admin in the right arm at 3:00PM on 02Jun05. Reportedly five minutes later the pt c/o neck pain and tingling of his fingers. It was not reported if the pt required treatment. Reportedly the pt recovered from these events. The reporter of this case is the same reporter of cases: 200501235, 200501236, 200501237, 200501238 and 200501239.
Was tested at a group residency on 1/10/22 Patient died at the group residency 1/17/2022
Total body aches / almost paralysis.  Faint / white as a sheet when tried to get up for bathroom.  Convulsive jerks horribly for several hours (reminded me of how a friend of mine reacted to strong cancer immunotherapy drugs in the hospital).  Tired to the point could barely move or get up for 9 hours.  When tried to get up to let my dogs out 4-6 hours after adverse reactions, almost fainted / had to lie down on the floor at my front door until I could get the strength to move again.  At one point, a hot flash / sweating like I never experienced before (was just after I tried to get up and had to lie on the floor).  Finally could get up and move without so much pain or feeling faint by 6 - 6:30 pm today (the day after getting the shot at 11 am yesterday).  NOTE;  I did drink 2.5 glasses of white wine the evening I got my shot before I felt bad (clearly, not a smart move).  Not sure if that made things worse.  I did take 2 Tylenol Rapid Release 500 mg/each before I went to bed but then didn?t take any more.
Started dizziness on 14th eve  neck pain , back pain, fatigue. went to ER. Blood test were taken to check counts and were reported normal. Fluid was injected via IV and advised Meclizine 25 mg. advised pain killers if needed. advised to contact ENT specialist if the condition continues after 2 to 3 days.
Approx. 12 pm started having chest tightness and chest pains. Client phones H.U. and instructed to go to ER. Client went to Medical and received IV fluids and had testing done ER doctor advised against second vaccine due to client's reaction. Client inst to follow up with PCP. Verbalized that she will make appointment today.
Shingles, short lived on back, was given Acyclocir and it cleared up. Took about a week.
Patient called around midnight complaining of severe wheezing, he called again in the morning adding headache to his symptoms. I advised patient to go to the hospital at his first phone call.
Fever. Nausea. Painful sore in mouth. Hard to swallow. Headaches.   This vaccine is political in nature. The vaccine should not make you ill.
This is a spontaneous report received from a contactable consumer or other non-HCP (patient). A 79-year-old female patient received the 2nd dose of BNT162B2 (Comirnaty, batch/lot# unknown), at the age of 79, on Feb 12, 2021, single dose, for COVID-19 immunisation. No medical history reported. The patient took concomitant medications. Vaccination history included the 1st dose of BNT162B2 (Comirnaty, batch/lot# EL0142), on Jan 22, 2021, for COVID-19 immunisation. The patient reported extreme fatigue/tiredness and malaise (feeling unwell) onset 2021, with outcome of not recovered. Additional information: The patient only on blood pressure medication. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Night sweats.; Extreme sweating during the night to the point of sheets being wet; This is a spontaneous report from a contactable other health care professional, the patient. A 52-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 23Mar2021 at 14:00 (at the age of 52-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to penicillin (PCN). The patient did not receive any other medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 02Mar2021 at 13:45 (at the age of 52-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. On 24Mar2021 at 00:00, the patient experienced night sweats, extreme sweating during the night to the point of sheets being wet. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcomes of the event night sweats and extreme (excessive) sweating during the night to the point of sheets being wet was recovered on 24Mar2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
In July I broke out into a cold sweat and soaking wet while lying down. I was overdoing much more than I ever do on a normal day. I told my grandson to grab me some mints because of the hypoglycemia and I started to feeling better. Then went to get lunch. Around  August 11th I woke up and something just wasn't feeling right, I called the Doctor and couldn't get in so they sent me to the hospital. When I went in they took my BP and it was over 200 and I normally carry a low bp so this was a shocker to me. My heart rate was low below 60. I had gone to an allergist a few days before that and they had asked if I normally have a low heart rate, which was unusual for me.  When I went to the PCP they said the ER was looking for a blood clot. The ER had me stay overnight. ER couldn't get the blood pressure down. I was on observation not a full admission. Doctor said he wished his heart was as strong as mind but they put me on a heart monitor. And BP medicine.
Patient received a single dose of Pfizer covid vaccine on 03/30/2021, the patient also received a single dose of Moderna on 01/23/2021. No adverse events were noted.
Fever; My temperature was about two Degrees above my normal; Sensation of nausea but I am not vomiting; it is not serious but uncomfortable; had unusual high number bowel movement; my weight was below normal; my pattern of my urination was less than half volume; Chills; Fatigue; elevated Heart rate; my heart rate is normally 60 and it was up around 90; This is a spontaneous report received from a contactable consumer (patient) reported for himself via a Pfizer regulatory authority. A 65-year-old male patient received bnt162b2 (Formulation: Solution for injection, Batch/Lot Number: EW0179), dose 1 via an unspecified route of administration on 20Jul2021 as single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient stated that his temperature was about two Degrees above my normal and would say it was lasted for about 30 hours. Now his normal temperature was about 97-97.5 Degrees. It was higher for a while up to 99.3, he had a sensation of nausea, not vomiting and it was not serious but uncomfortable. He didn't have diarrhea but had unusual high number bowel movements that day. He had a bowel movement for about 18 hours which it was very unusual, weight mention was below normal, the patient generally drinks a lot of water and  have pretty good familiarity with his pattern of his urination but it was less than half volume that he normally produce. Recovered back to normal after 30 hour time period. He did have a period of enough chills shivering put on jacket, He had pretty strong fatigue and it seems like my elevated Heart rate and his blood pressure was normal, his heart rate was normally 60 and it was up around 90. He also have a pulse auxometer, my normal reading were usually "96-98" (not clarified). Now the patient feel much better now, some minor Local reaction; delayed reaction; but in his suspicion that was most likely a systemic reaction". The patient reported that on Friday he began to experience local side effects. Seeking information on whether these could be from the vaccine or covid 19 infection, also seeking information if he can get the second dose of the Pfizer BioNtech covid 19 vaccine with a current covid 19 infection and also queried that can he get the second dose of the Pfizer BioNtech covid 19 vaccine if it has been longer than 21 days since his first dose. The patient also said that about 17 days from the first dose, he had symptoms. He wanted to know if this could be the delayed reaction. He said he "extremely" (not clarified) followed the protocol when it came to "isolation" (further not clarified). He was scheduled for the second dose tomorrow (10Aug2021)." Consumer stated, "I am not concerned about reaction, I am concerned about how long it will take, I have to take my second shot." Outcome of the events was unknown.
Post vax, this pt developed a moderate skin rash and hives. *Follow-up report on 2/12/03: From add'l info. received on 8/5/99, it was reported that the PT received TD as a routine vaccination on the left deltoid IM. Add'l PT, vaccine and responsible MD info. was also provided. From follow-up #1 correspondence received on 5/14/01, it was reported that the PT recovered from this experience. This case is closed.
Pt with rash located between breasts, some diffusely inferior lymphadenopathy, papular rash associated. Pt was treated with ? dose pack and Benadryl and Allegra for seasonal allergic rhinitis. Symptoms X 5 day progression.
This spontaneous report was received from a medical assistant, concerning multiple patients of unknown age and genders. The patients' medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported. Between 01-AUG-2018 and 06-AUG-2018, the patients were administered improperly stored PROQUAD subcutaneously, for prophylaxis, lot #R002936, albumin status rHA and expiration date 29-JUL-2019 (strength, dose and frequency were not reported), which was reconstituted with a properly stored sterile diluent (MERCK). No adverse effects were reported. The temperatures of excursion were reported as 6°F to 14°F during a time frame of 1 hour and 15 minutes and 28.5°F during a time frame of 45 minutes. There was no previous temperature excursion reported. There was a digital data logger involved. Sender's Comments: US-009507513-1808USA009441: US-009507513-1808USA009442: US-009507513-1808USA009443: US-009507513-1808USA009444: US-009507513-1808USA009445: US-009507513-1808USA009446: US-009507513-1808USA009447: US-009507513-1808USA003515.
I got the shot on my left arm and now I have a burning pain in my left armpit and in my left breast. It is a 4 on a 1 to 10 scale of pain. I noticed it June 2nd but today it is hard to ignore.
The patient received a Moderna COVID booster.  When he arrived he was sweaty.  He was asked if he was sick and he stated no verbally and on his VAR.  The vaccine was administered.  Approximately 20 minutes after his vaccine he said he felt tingly all over and he said he might vomit. The patient also said he felt as if his throat was swelling shut.  The patient was seated, and blood pressure and o2 assessed.  BP was 157/94, O2 was 97.  Cold compresses were applied to the patients neck and emergency was called. The patient was given oral diphenhydramine 50mg which he swallowed with water.  He was then given epinephrine 0.3mg IM in the right thigh.  The patient said he immediately felt better. The squad arrived and transported him to the ER.  The patient informed the squad that he had started a new medication within the last 24 hours as well (med unknown).  The patient was transported to the hospital.  Upon follow up with the hospital, we received additional information.  The patient was seen in a different ER this morning  (1/28/22 8:58am electronic stamp) but did not disclose this information.  The patient was assessed for a possible abscess, but the findings from the ER are not clear.
This case was reported by a consumer and described the occurrence of vomiting in a 35-year-old male subject who was vaccinated with TWINRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medications conditions included hay fever. There were no concurrent medications. On 13 June 2012 at 17:45 the subject received 2nd dose of TWINRIX in the left arm. On 13 June 2012, 285 minutes after vaccination with TWINRIX (at the time the subject went to bed at 22:30), the subject experienced discomfort in his stomach (gastric discomfort). Later, at midnight on 14 June 2012 (375 minutes after vaccination with 2nd dose of TWINRIX), the subject experienced vomiting, fever (99.3 degrees), malaise, stomach pain and diarrhea. At the time of reporting, the subject reported that he had not vomited in 7 hours and considered the symptom resolved; however, he reported still suffering from the other symptoms, although they were improved. The subject also reported that he had a little dizziness and tiredness about an hour following his 1st vaccination with TWINRIX on an unspecified date. Outcome was not reported.
Vomiting this evening both shots were given (PREVNAR 07/31/2006 and DAPTACEL 07/24/2006).  Symptoms resolved in less than 24 hours.
This spontaneous report as received from a physician refers to an around 70 years old female patient. The patient's medical history and drug reactions or allergies were not reported. On an unknown date, a few years ago, the patient was vaccinated with ZOSTAVAX (dosage information and lot number were not reported). Concomitant medications were not reported). On an unknown date approximately in May 2016, reported as "a month ago", the patient experienced Bell's palsy with legions (ear abrasion) in an unspecified ear for which the patient sought attention by calling the physician. At the reporting time, the outcome of Bell's palsy and ear abrasion was unknown as well as the causality assessment between them and ZOSTAVAX. No product quality complaint was involved. Upon internal review "Bell's palsy" was determined to be medically significant. Additional information has been requested.
No addtional adverse event reported; Unspecified child was given an adult VAQTA formulation; This spontaneous report was received from an nurse regarding a 6 months male patient via company representative. The patient's concurrent conditions, pertinent medical history, drug reactions, allergies, and concomitant therapies were not reported.   On 03-DEC-2019, the patient received an adult Hepatitis A Vaccine, Inactivated (VAQTA) lot number S012250, expiration date 07-JUL-2020 (dose, and route of administration was not reported) (product administered to patient of inappropriate age). No additional adverse event reported. The patient did not received medical intervention.
breakthrough COVID; breakthrough COVID; was sick; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age (reported as under 40 years old) received bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration in Feb2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE, then dose 2 via an unspecified route of administration in Mar2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included diabetes from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient who had Pfizer COVID-19 vaccine in Feb2021 and then got another dose in Mar2021, 21 days after the first dose, had breakthrough COVID and was sick but not hospitalized in Jul2021. The patient underwent lab tests and procedures which included sars-cov-2 test reported as breakthrough COVID positive in Jul2021. The outcome of the events was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Stomach pain; back pain; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), ABDOMINAL PAIN UPPER (Stomach pain) and BACK PAIN (back pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     The patient's past medical history included Amputation (One of the lower limbs amputated.). Concomitant products included OMEPRAZOLE, MAGNESIUM OXIDE, DEXTROMETHORPHAN POLISTIREX (ROBITUSSIN 12 HOUR COUGH RELIEF), CALCIUM, ATORVASTATIN, MONTELUKAST SODIUM (SINGULAIR), PREGABALIN (LYRICA), ESCITALOPRAM OXALATE (LEXAPRO), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), POTASSIUM, VITAMIN D2, NADOLOL, TERBUTALINE and HYDROMORPHONE.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced FATIGUE (Fatigue). On 14-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain) and BACK PAIN (back pain). At the time of the report, FATIGUE (Fatigue), ABDOMINAL PAIN UPPER (Stomach pain) and BACK PAIN (back pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment information provided as, Promethazine. Concomitant medications also include, Tomalin, Proguard, Sulphate, Bath Lysine.   This case was linked to MOD-2021-079114 (E2B Linked Report).; Sender's Comments:  MOD-2021-079114:
Numbness and tingling in left hand, right hand fingertips. Numbness/tingling in left foot (toes and sole). Also noticed heaviness, "dullness" in left arm.
Child developed flat, red, splotchy rash on arms, legs and face evening of 9/6/04. No fever. No other sx. Mom gave child Benadryl evening of 9/6 and rash seemed to resolve. Rash reoccurred evening of 9/7/ and mom gave another dose of Benadryl. No noticeable rash this AM (9/8). Child had been eating alot of nuts on 9/6 and 9/7. Advised mom to contact MD if rash reoccurs for evaluation of rash and to f/u with allergy testing.